XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Shares at beginning of year (in shares) at Dec. 31, 2017     71,494           45,167
Balance at beginning of year at Dec. 31, 2017 $ 134,277 $ (179) $ 715 $ 437,394 $ 100   $ 195,143 $ (179) $ (499,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 57,980           57,980    
Issuance for stock-based compensation and dividend equivalents, net of forfeitures (in shares)     357            
Issuance for stock-based compensation and dividend equivalents, net of forfeitures 0   $ 4 762     (766)    
Exercise of stock options (in shares)     5           1
Exercise of stock options 0     46         $ (46)
Stock-based compensation expense $ 8,797     8,797          
Employee stock purchase plan (in shares) (19)               (19)
Employee stock purchase plan $ 549     338         $ 211
Dividends (14,870)           (14,870)    
Defined benefit pension plans, net of tax 881       881        
Change in fair value of interest rate swap, net of tax 315       315        
Repurchases of common stock (in shares)                 673
Repurchases of common stock (19,419)               $ (19,419)
Shares at end of year (in shares) at Dec. 31, 2018     71,856           45,822
Balance at end of year at Dec. 31, 2018 168,331 0 $ 719 447,337 1,296 $ 168 237,308 (168) $ (518,329)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 130,862           130,862    
Issuance for stock-based compensation and dividend equivalents, net of forfeitures (in shares)     346            
Issuance for stock-based compensation and dividend equivalents, net of forfeitures 0   $ 3 846     (849)    
Exercise of stock options (in shares)     0           0
Exercise of stock options 0     0         $ 0
Stock-based compensation expense $ 11,007     11,007          
Employee stock purchase plan (in shares) (17)               (17)
Employee stock purchase plan $ 558     355         $ 203
Dividends (16,608)           (16,608)    
Defined benefit pension plans, net of tax (2,183)       (2,183)        
Change in fair value of interest rate swap, net of tax (807)       (807)        
Repurchases of common stock (in shares)                 3,472
Repurchases of common stock (123,897)               $ (123,897)
Shares at end of year (in shares) at Dec. 31, 2019     72,202           49,277
Balance at end of year at Dec. 31, 2019 167,263 $ (214) $ 722 459,545 (1,526)   350,545 $ (214) $ (642,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 56,039           56,039    
Issuance for stock-based compensation and dividend equivalents, net of forfeitures (in shares)     398            
Issuance for stock-based compensation and dividend equivalents, net of forfeitures 0   $ 4 934     (938)    
Stock-based compensation expense $ 11,595     11,595          
Employee stock purchase plan (in shares) (19)               (19)
Employee stock purchase plan $ 549     304         $ 245
Dividends (16,787)           (16,787)    
Defined benefit pension plans, net of tax (1,706)       (1,706)        
Change in fair value of interest rate swap, net of tax (1,191)       (1,191)        
Repurchases of common stock (in shares)                 1,169
Repurchases of common stock (35,613)               $ (35,613)
Shares at end of year (in shares) at Dec. 31, 2020     72,600           50,427
Balance at end of year at Dec. 31, 2020 $ 179,935   $ 726 $ 472,378 $ (4,423)   $ 388,645   $ (677,391)